Boston Scientific's Jeffrey Mirviss sells $1.37 million in stock By...

Published on 13 Feb 2025 on Investing.com

Jeffrey B. Mirviss, Executive Vice President and President of Peripheral Interventions at Boston...

Read the rest of the article

Start tracking your investments with Statfolio

Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing...

Zacks · via Yahoo Finance 20 Feb 2025

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quart...

Insider Monkey · via Yahoo Finance 20 Feb 2025

On Wednesday, Fitch Ratings upgraded Boston Scientific Corporation's (NASDAQ:NYSE:BSX) Long-Term...

Investing.com 19 Feb 2025

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quart...

Insider Monkey · via Yahoo Finance 19 Feb 2025

We recently compiled a list of the 10 Best Momentum Stocks to Buy According to Hedge Funds. In th...

Insider Monkey · via Yahoo Finance 14 Feb 2025

Jeffrey B. Mirviss, Executive Vice President and President of Peripheral Interventions at Boston...

Investing.com 13 Feb 2025

John Bradley Sorenson, Executive Vice President of Global Operations at Boston Scientific Corp...

Investing.com 13 Feb 2025

We recently compiled a list of the 12 Best Fundamental Stocks to Buy Now. In this article, we are...

Insider Monkey · via Yahoo Finance 27 Jan 2025

Boston Scientific's (NYSE:BSX) stock is up by a considerable 12% over the past three months....

Simply Wall St. · via Yahoo Finance 19 Jan 2025

BSX Ahead of Moving Averages Too Going by the technical indicators, the stock is trading above it...

Zacks · via Yahoo Finance 15 Jan 2025